134 related articles for article (PubMed ID: 7482298)
21. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
[TBL] [Abstract][Full Text] [Related]
22. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
23. [Changes in serum RNase activities in chronic phase and acute crisis of chronic myelocytic leukemia].
Maruoka K; Yamanaka M; Misago M; Nakata K; Tsukada J; Nagata K; Sato T; Mori N; Oda S; Chiba S
Rinsho Ketsueki; 1989 Jul; 30(7):988-93. PubMed ID: 2810801
[TBL] [Abstract][Full Text] [Related]
24. Immunophenotype and ultrastructural studies in blast crisis of chronic myeloid leukemia.
Nair C; Chopra H; Shinde S; Barbhaya S; Kumar A; Dhond S; Yejamanam B; Sapre R; Chougule A; Advani S
Leuk Lymphoma; 1995 Oct; 19(3-4):309-13. PubMed ID: 8535224
[TBL] [Abstract][Full Text] [Related]
25. Predictors for prognosis of chronic myelocytic leukemia.
Chen SS; Zhang HF; Xue WT; Li K; Wang P; Lui Y
Chin Med J (Engl); 1993 Oct; 106(10):760-2. PubMed ID: 7913433
[TBL] [Abstract][Full Text] [Related]
26. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
Straetmans N; Ma DD; Nevell DF; Arthur C
Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
[TBL] [Abstract][Full Text] [Related]
27. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
[TBL] [Abstract][Full Text] [Related]
28. [Enzymatic markers in chronic myeloleukemia and their importance for identifying a blast crisis].
Filanovskaia LI; Togo AV; Shcherbakova EG; Rogaleva EIu; Blinov MN
Vopr Onkol; 1990; 36(9):1053-8. PubMed ID: 2122593
[TBL] [Abstract][Full Text] [Related]
29. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
Klco JM; Kreisel FH; Zehnbauer BA; Kulkarni S; Hassan A; Frater JL
Am J Hematol; 2008 Dec; 83(12):901-7. PubMed ID: 18932238
[TBL] [Abstract][Full Text] [Related]
30. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
31. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia.
Hirayama Y; Kohgo Y; Kanisawa Y; Fujii S; Ikeda K; Matsunaga T; Ito Y; Sakamaki S; Niitsu Y
Int J Hematol; 1993 Jun; 57(3):265-8. PubMed ID: 8364189
[TBL] [Abstract][Full Text] [Related]
32. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
33. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
34. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
[TBL] [Abstract][Full Text] [Related]
35. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
[TBL] [Abstract][Full Text] [Related]
36. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
[TBL] [Abstract][Full Text] [Related]
37. [The immunological indices of patients with chronic myeloleukemia at the blast crisis stage].
Romanova AF; Fedorovskaia EA; Pesotskaia LA
Vrach Delo; 1991 Apr; (4):65-7. PubMed ID: 2063572
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypic and genotypic characteristics of chronic myelogenous leukemia in blast crisis.
Yen CC; Liu JH; Wang WS; Fan FS; Chiou TJ; Tai CJ; Yang MH; Chao TC; Hsiao LT; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Nov; 63(11):785-91. PubMed ID: 11155753
[TBL] [Abstract][Full Text] [Related]
39. Repeated blast crisis (BC) of changing morphology, immunologic phenotype and cytogenetics in chronic myeloid leukemia (CML).
Jehn U; Mittermüller J; Greither L; Clemm C; Heinemann V; Lorenz T; Gross HJ
Anticancer Res; 1989; 9(6):1721-3. PubMed ID: 2627124
[TBL] [Abstract][Full Text] [Related]
40. [Monocytic crisis in chronic myeloid leukemia: a case report].
Sugita K; Nakazawa S; Mori T; Nishino K; Abe T; Gonda T; Aya M; Osano M; Takane K; Okazaki T
Rinsho Ketsueki; 1989 Mar; 30(3):376-81. PubMed ID: 2769961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
